☆ 4.8 Article

Exploitation of tumor antigens and construction of immune subtype classifier for mRNA vaccine development in bladder cancer

FRONTIERS IN IMMUNOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Biotechnology & Applied Microbiology

Identification of neoantigens for individualized therapeutic cancer vaccines

Franziska Lang et al.

Summary: This Review discusses the use of tumor-specific neoantigens in anticancer vaccines and introduces the mechanisms of neoantigen T cell recognition, as well as computational approaches to predict which neoantigens might confer proficient antitumor immunity in patients. Individualized treatment approaches are required to harness the full potential of the unique cancer mutations in each patient. Computational algorithms and machine-learning tools can be used to identify mutations, prioritize T cell-recognized antigens, and design personalized vaccines for each patient.

NATURE REVIEWS DRUG DISCOVERY (2022)

添加到收藏夹

Article Pathology

The impact of grading scheme on non-muscle invasive bladder cancer progression: potential utility of hybrid grading schemes

Michelle R. Downes et al.

Summary: This study found that combining the World Health Organization (WHO) 1973 and 2004 grading systems into a hybrid three-tier or four-tier system can better stratify patients with non-muscle invasive bladder cancer (NMIBC). This new grading system showed better predictive ability for patients' progression and event-free survival.

PATHOLOGY (2022)

添加到收藏夹

Article Oncology

Immune profiles and DNA methylation alterations related with non-muscle-invasive bladder cancer outcomes

Ji-Qing Chen et al.

Summary: This study used DNA methylation profiles and cell type analysis to identify that increasing CD4T and CD8T cell proportions were associated with a decreased hazard of tumor recurrence or death in NMIBC patients, while increasing monocyte proportion and mdNLR were associated with an increased hazard. Additionally, 2528 CpGs associated with tumor recurrence or death were identified through epigenome-wide association study.

CLINICAL EPIGENETICS (2022)

添加到收藏夹

Article Oncology

Targeting the tumor mutanome for personalized vaccination in a TMB low non-small cell lung cancer

Katy McCann et al.

Summary: This study demonstrates the feasibility of efficiently identifying tumor-specific neoantigens and targeting them with vaccination in tumors with a low mutational burden, showing promising potential for successful clinical exploitation.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

添加到收藏夹

Review Oncology

MMP9: A Tough Target for Targeted Therapy for Cancer

Katarzyna Augoff et al.

Summary: MMP9, a protease with diverse functions, plays a crucial role in tumorigenesis by regulating cancer cell migration, epithelial-to-mesenchymal transition, immune response, angiogenesis, and tumor microenvironment formation. However, the complicated regulation mechanism and high homology with other MMP family members make it difficult to develop effective and safe MMP9 inhibitors as anticancer drugs. The recent development of blocking antibodies shows promise, but further research is needed to fully understand the mechanisms of MMP9 in tumorigenesis and develop new therapies targeting MMP9.

CANCERS (2022)

添加到收藏夹

Article Oncology

Identification of Novel Tumor Antigens and the Immune Landscapes of Bladder Cancer Patients for mRNA Vaccine Development

Guixin Wang et al.

Summary: This study identified candidate tumor-specific antigens and suitable populations for mRNA vaccines in bladder cancer (BLCA) through comprehensive multi-omics analysis.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Article Computer Science, Theory & Methods

Identification of mRNA vaccines and conserved ferroptosis related immune landscape for individual precision treatment in bladder cancer

Cheng-Peng Gui et al.

Summary: This study identified the landscape of ferroptosis-induced tumor microenvironment in bladder cancer, which can aid in mRNA vaccine development and selecting suitable patients for precision treatment.

JOURNAL OF BIG DATA (2022)

添加到收藏夹

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Review Oncology

The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker

Denis L. Jardim et al.

Summary: Tumor mutational burden (TMB) reflects cancer mutation quantity and correlates with better outcomes of immune checkpoint inhibitors (ICIs). However, TMB as a biomarker is imperfect and a composite predictor including critical variables is needed.

CANCER CELL (2021)

添加到收藏夹

Review Oncology

The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers

Jinyan Wang et al.

Summary: IGF2BP2 is an RNA-binding protein that regulates cellular metabolism and cancer development by post-transcriptional regulation. It is also an independent prognostic factor for multiple cancer types.

CANCER CELL INTERNATIONAL (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carcinoma

Hang Xu et al.

Summary: The study identified TOP2A, NCF4, FMNL1, and DOK3 as potential effective neoantigens for KIRC mRNA vaccine development and characterized two immune subtypes, RIS1 and RIS2, in KIRC. Patients with RIS2 tumors may benefit more from mRNA vaccination, indicating potential for personalized cancer therapy.

MOLECULAR CANCER (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

mRNA vaccine for cancer immunotherapy

Lei Miao et al.

Summary: mRNA vaccines have emerged as a promising platform for cancer immunotherapy, showcasing high potency, safe administration, rapid development potentials, and cost-effective manufacturing. However, challenges such as stability, innate immunogenicity, and inefficient in vivo delivery restrict their applications. In addressing these challenges, structural modifications and formulation methods are being researched to enhance the anti-tumor immune response.

MOLECULAR CANCER (2021)

添加到收藏夹

Article Immunology

Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza

Sudha Chivukula et al.

Summary: The recent approval of mRNA vaccines for emergency use against COVID-19 is likely to accelerate the development of mRNA-based vaccines targeting a wide range of infectious diseases. This vaccine modality promises comparable potency while accelerating the development and deployment of vaccine doses. Demonstrated successfully for single antigen vaccines, the technology could be optimized for complex multi-antigen vaccines.

NPJ VACCINES (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Clinical and immunological effects of mRNA vaccines in malignant diseases

Annkristin Heine et al.

Summary: mRNA-based therapeutics are considered as a novel and efficient class of drugs, with recent studies demonstrating their potential efficacy in treating various malignant and infectious diseases. Direct application of mRNA or electroporation into dendritic cells can induce immune responses and produce protective antibodies.

MOLECULAR CANCER (2021)

添加到收藏夹

Article Oncology

Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study

Arjun Balar et al.

Summary: This study evaluated the efficacy and safety of pembrolizumab, a PD-1 inhibitor, in patients with BCG-unresponsive non-muscle-invasive bladder cancer. The results showed that pembrolizumab monotherapy was well-tolerated and demonstrated promising antitumor activity in this patient population.

LANCET ONCOLOGY (2021)

添加到收藏夹

Review Immunology

From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape

Chiranjib Chakraborty et al.

Summary: mRNA vaccines have emerged as a significant type of therapeutic, especially with the recent approval of COVID-19 mRNA vaccines. These vaccines have sparked interest in the pharmaceutical and biotechnology industries, offering new hope for the future of medicine.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Oncology

Characterization of hypoxia response patterns identified prognosis and immunotherapy response in bladder cancer

Rui Cao et al.

Summary: This study identified different hypoxia response patterns in bladder cancer patients, showing that the low HPXscore group had immune activation and high DNA damage repair, highlighting an immune-inflamed phenotype, while the high HPXscore group exhibited stromal-related pathway activation, indicating a T cell suppressive and immune-excluded phenotype. The HPXscore was also found to be an independent prognostic factor and a good predictor for immunotherapeutic outcomes in bladder cancer.

MOLECULAR THERAPY-ONCOLYTICS (2021)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Comprehensive integrative profiling of upper tract urothelial carcinomas

Xiaoping Su et al.

Summary: This study identifies the crosstalk between genetic, epigenetic, and immune alterations in upper tract urothelial carcinomas and their role in shaping muscle invasiveness and patient outcome. Additionally, mutations of ZFP36 family genes are identified as a significant factor, with specific epi-clusters associated with muscle-invasive status and patient outcome.

GENOME BIOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Hsa_circ_0001361 promotes bladder cancer invasion and metastasis through miR-491-5p/MMP9 axis

Feng Liu et al.

ONCOGENE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader

Xiaoge Hu et al.

CELL DEATH AND DIFFERENTIATION (2020)

添加到收藏夹

Review Immunology

The promise of mRNA vaccines: a biotech and industrial perspective

Nicholas A. C. Jackson et al.

NPJ VACCINES (2020)

添加到收藏夹

Review Biotechnology & Applied Microbiology

TMB: a promising immune-response biomarker, and potential spearhead in advancing targeted therapy trials

Khalil Choucair et al.

CANCER GENE THERAPY (2020)

添加到收藏夹

Review Chemistry, Medicinal

Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview

Subha Mondal et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

添加到收藏夹

Review Oncology

Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors

Vid Leko et al.

CANCER CELL (2020)

添加到收藏夹

Article Oncology

Safety and Efficacy of Andecaliximab (GS-5745) Plus Gemcitabine andNab-Paclitaxelin Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I Study

Johanna Bendell et al.

ONCOLOGIST (2020)

添加到收藏夹

Review Medicine, General & Internal

Bladder Cancer: A Review

Andrew T. Lenis et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Review Oncology

A Perspective on Cell Therapy and Cancer Vaccine in Biliary Tract Cancers (BTCs)

Shuting Han et al.

CANCERS (2020)

添加到收藏夹

Article Oncology

IGF2BP2 Promotes Liver Cancer Growth Through an m6A-FEN1-Dependent Mechanism

Jian Pu et al.

FRONTIERS IN ONCOLOGY (2020)

添加到收藏夹

Article Oncology

Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guerin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy

Cyrill A. Rentsch et al.

ONCOIMMUNOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Cancer stemness, intratumoral heterogeneity, and immune response across cancers

Alex Miranda et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

The Insulin-Like Growth Factor 2 mRNA Binding Protein IMP2/IGF2BP2 is Overexpressed and Correlates with Poor Survival in Pancreatic Cancer

Charlotte Dahlem et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

添加到收藏夹

Article Critical Care Medicine

Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial

Michele Tameris et al.

LANCET RESPIRATORY MEDICINE (2019)

添加到收藏夹

Review Urology & Nephrology

T1 bladder cancer: current considerations for diagnosis and management

Brian Jordan et al.

NATURE REVIEWS UROLOGY (2019)

添加到收藏夹

Article Biology

MMP9 modulates the metastatic cascade and immune landscape for breast cancer anti-metastatic therapy

Mark Owyong et al.

LIFE SCIENCE ALLIANCE (2019)

添加到收藏夹

Article Oncology

Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies

Roberta Zappasodi et al.

CANCER CELL (2018)

添加到收藏夹

Article Oncology

Andecaliximab/GS-5745 Alone and Combined with mFOLFOX6 in Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Results from a Phase I Study

Manish A. Shah et al.

CLINICAL CANCER RESEARCH (2018)

添加到收藏夹

Review Immunology

Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors

Kristian M. Hargadon et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2018)

添加到收藏夹

Review Biotechnology & Applied Microbiology

mRNA vaccines - a new era in vaccinology

Norbert Pardi et al.

NATURE REVIEWS DRUG DISCOVERY (2018)

添加到收藏夹

Review Multidisciplinary Sciences

Cancer immunotherapy using checkpoint blockade

Antoni Ribas et al.

SCIENCE (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes

Elias J. Sayour et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

添加到收藏夹

Article Multidisciplinary Sciences

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

Sanjeev Mariathasan et al.

NATURE (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

Peng Jiang et al.

NATURE MEDICINE (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Clinical and in vitro analysis of Osteopontin as a prognostic indicator and unveil its potential downstream targets in bladder cancer

Janet P. C. Wong et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)

添加到收藏夹

Article Cell Biology

Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade

Pornpimol Charoentong et al.

CELL REPORTS (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

A. Gordon Robertson et al.

CELL (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

Willy Hugo et al.

CELL (2016)

添加到收藏夹

Article Biochemical Research Methods

Robust enumeration of cell subsets from tissue expression profiles

Aaron M. Newman et al.

NATURE METHODS (2015)

添加到收藏夹

Letter Immunology

Overexpression of IGF2 mRNA-Binding Protein 2 (IMP2/p62) as a Feature of Basal-like Breast Cancer Correlates with Short Survival

A. Barghash et al.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2015)

添加到收藏夹

Review Urology & Nephrology

Epidemiology and Risk Factors of Urothelial Bladder Cancer

Maximilian Burger et al.

EUROPEAN UROLOGY (2013)

添加到收藏夹

Article Urology & Nephrology

Bladder cancer: Epidemiology, staging and grading, and diagnosis

Z Kirkali et al.

UROLOGY (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.